COVID 19 & Corticosteroids

Thanks @David_Martin for sharing article, it is helpful.

After the research from UK the benefits of Dexamethasone , our institution is also planning to start the same

I have reviewed the preprint from the RECOVERY trial. I am surprised that based on that data IDSA and SCCM are recommending dexamethasone in COVID-19 ARDS. Our institution has added it as a “consideration”. The data is clearly not strong enough to recommend. There is clear data to recommend AGAINST steroids in COVID-19 if patients are not on oxygen therapy. Due to dexamethasone shortages and concerns from our peds oncology colleagues about availability for them, we are recommending alternatives to dexamethasone if one is considering steroids for ARDS.

We have seen a good response for Dexa in our ICU pt

Thank you to our supporters

Thank you to those that provided an unrestricted educational grant
Pfizer | Novartis | Mallinckrodt
The Society of Critical Care Medicine (SCCM) is the largest non-profit medical organization dedicated to promoting excellence and consistency in the practice of critical care. With members in more than 100 countries, SCCM is the only organization that represents all professional components of the critical care team. The Society offers a variety of activities that ensures excellence in patient care, education, research and advocacy. Read more
500 Midway Drive, Mount Prospect, IL 60056 USA

Phone: +1 847 827-6888
Fax: +1 847-439-7226
© Society of Critical Care Medicine. All rights reserved.
The Society of Critical Care Medicine, SCCM and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.
Like SCCM on Facebook  @SCCM on Twitter  SCCM on LinkedIn  Subscribe to the SCCM YouTube Channel  Donate to SCCM